Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Biopharma Cred. (BPCR) Share Price

Price $0.908 on 09-01-2026 at 19:30:05
Change $0.002 0.22%
Buy $0.908
Sell $0.904
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Buy 31,063.00 at $0.908
Day's Volume: 570,269
Last Close: $0.908
Open: $0.904
ISIN: GB00BDGKMY29
Day's Range $0.902 - $0.91
52wk Range: $0.80 - $0.94
Market Capitalisation: $1.03b
VWAP: $0.906746
Shares in Issue: 1.13b

Sector: Closed End Investments

Biopharma Cred. (BPCR) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 31,063 $0.908 Suspected BUY Trade
 16:35:18 - 09-Jan-26
Buy* 10,521 $0.908 Automatic Execution
 16:29:51 - 09-Jan-26
Buy* 545 $0.908 Automatic Execution
 16:29:34 - 09-Jan-26
Buy* 934 $0.908 Automatic Execution
 16:29:30 - 09-Jan-26
Buy* 11,436 $0.91 Automatic Execution
 16:27:53 - 09-Jan-26
Sell* 31,602 $0.906 Automatic Execution
 16:27:53 - 09-Jan-26
Sell* 50,000 $0.906 Automatic Execution
 16:27:53 - 09-Jan-26
Sell* 5,697 $0.906 Automatic Execution
 16:27:53 - 09-Jan-26
Sell* 3,141 $0.906 Automatic Execution
 16:27:53 - 09-Jan-26
Sell* 2,556 $0.906 Automatic Execution
 16:27:53 - 09-Jan-26
See more Biopharma Cred. trades

Biopharma Cred. (BPCR) Share Price History

Time period:
to
Date Open High Low Close Volume
9th Jan 2026 (Fri) 0.904 0.91 0.902 0.908 570,269
8th Jan 2026 (Thu) 0.908 0.908 0.896 0.906 772,512
7th Jan 2026 (Wed) 0.908 0.918 0.908 0.908 667,421
6th Jan 2026 (Tue) 0.91 0.918 0.91 0.91 1,201,817
5th Jan 2026 (Mon) 0.93 0.93 0.91 0.91 2,246,118
2nd Jan 2026 (Fri) 0.926 0.926 0.918 0.918 306,031
1st Jan 2026 (Thu) 0.916 0.916 0.916 0.916 0
31st Dec 2025 (Wed) 0.916 0.916 0.916 0.916 432,608
30th Dec 2025 (Tue) 0.908 0.92 0.904 0.92 838,258
29th Dec 2025 (Mon) 0.908 0.92 0.90 0.908 1,329,841
26th Dec 2025 (Fri) 0.898 0.898 0.898 0.898 0
25th Dec 2025 (Thu) 0.898 0.898 0.898 0.898 0
24th Dec 2025 (Wed) 0.902 0.904 0.898 0.898 290,346
23rd Dec 2025 (Tue) 0.91 0.91 0.896 0.902 700,087
22nd Dec 2025 (Mon) 0.91 0.91 0.904 0.904 504,430
19th Dec 2025 (Fri) 0.904 0.91 0.904 0.908 585,539
18th Dec 2025 (Thu) 0.90 0.91 0.90 0.906 1,786,374
17th Dec 2025 (Wed) 0.902 0.91 0.90 0.91 749,292
16th Dec 2025 (Tue) 0.90 0.91 0.896 0.898 1,013,495
15th Dec 2025 (Mon) 0.902 0.908 0.90 0.90 454,383
12th Dec 2025 (Fri) 0.912 0.912 0.90 0.90 873,932
11th Dec 2025 (Thu) 0.906 0.91 0.90 0.91 583,971
See more Biopharma Cred. price history

Biopharma Cred. (BPCR) Regulatory News

Date Source Headline
30th Dec 2025 1:32 pm RNS STATEMENT RE COLLEGIUM PREPAYMENT
30th Dec 2025 1:32 pm RNS STATEMENT RE COLLEGIUM PREPAYMENT
19th Dec 2025 4:00 pm RNS Net Asset Value(s) and Monthly Factsheet
21st Nov 2025 4:00 pm RNS Net Asset Value(s) and Monthly Factsheet
4th Nov 2025 3:29 pm RNS Director/PDMR Shareholding
24th Oct 2025 4:00 pm RNS Net Asset Value(s) and Monthly Factsheet
21st Oct 2025 7:00 am RNS UPDATES ON INVESTMENT PORTFOLIO
7th Oct 2025 7:00 am RNS NEW INVESTMENT OF US$30 MILLION
23rd Sep 2025 4:00 pm RNS Net Asset Value(s) and Monthly Factsheet
22nd Sep 2025 7:00 am RNS Half-year Report
See more Biopharma Cred. regulatory news

Biopharma Cred. (BPCR) Share News

IN BRIEF: BioPharma Credit receives funds from loan prepayment

30th Dec 2025 19:48

BioPharma Credit PLC - London-based closed-ended investment company focused on life sciences industry - Notes Collegium Pharmaceutical Inc's repayment in full of a USD645.8 million senior secured term loan, in which BioPharma Credit had invested USD290.4 million in July 2024. It receives prepayment proceeds of USD261.4 million of principal with USD2.6 million of prepayment fees and USD5.3 million of accrued interest. BioPharma Credit says its cash balance is now around USD405 million. Read More

UK dividends calendar - next 7 days

24th Oct 2025 11:25

Read More

IN BRIEF: Biopharma Credit increases loan commitment to Valneva

7th Oct 2025 11:22

BioPharma Credit PLC - London-based closed-ended investment company focused on life sciences industry - Provides a senior secured loan to Valneva Austria GmbH, a subsidiary of Valneva SE. Initial tranche is expected to be funded in the coming weeks, with BioPharma investing USD30 million and BioPharma Credit Investments V (Master) LP investing an additional USD185 million in parallel, and BioPharma acting as collateral agent. "Further tranches of up to USD285 million for potential business development are subject to mutual agreement by the parties with loan allocations to be determined at such time," BioPharma adds. The loan to Valneva will mature in October 2030 and bear an interest of 9.00% per year. Read More

BioPharma Credit expects pipeline growth as net asset value ticks up

22nd Sep 2025 09:37

(Alliance News) - BioPharma Credit PLC on Monday said net asset value increased, while the net income for the first half of the year substantially covered its annual dividend target. Read More

UK earnings, trading statements calendar - next 7 days

15th Sep 2025 15:29

Read More

See more Biopharma Cred. news
FTSE 100 Latest
Value10,124.60
Change79.91

Login to your account

Forgot Password?

Not Registered